Search

Your search keyword '"Adam Dangoor"' showing total 12 results
Start Over "Adam Dangoor" Publication Type News
12 results on '"Adam Dangoor"'

1. Southmead Hospital Reports Findings in BCR-ABL Tyrosine Kinase Inhibitors (A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinib)

Subjects
Elsevier Science Inc. -- Reports, Tyrosine -- Reports, Tumors -- Reports, Antineoplastic agents -- Reports, Phenols -- Reports, Databases -- Reports, Periodical publishing -- Reports, Antimitotic agents -- Reports, CD-ROM catalog, Database, CD-ROM database, Computers
Abstract

2022 OCT 11 (VerticalNews) -- By a News Reporter-Staff News Editor at Information Technology Newsweekly -- New research on Drugs and Therapies - BCR-ABL Tyrosine Kinase Inhibitors is the subject [...]

Published
2022

2. NHS Cancer Alliance Implements Inspirata AI to Improve Clinical Trial Access for South West Patients

Subjects
Healthcare industry software -- Product development, Cancer patients, Natural language interfaces -- Product development, Clinical trials, Computational linguistics -- Product development, Language processing -- Product development, Cancer, Banking, finance and accounting industries, Business
Abstract

Bristol, United Kingdom, Feb 10, 2022 (GLOBE NEWSWIRE via COMTEX) -- Cancer informatics and digital pathology provider Inspirata and the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance (SWAG) announced today [...]

Published
2022

3. NHS Cancer Alliance Implements Inspirata AI to Improve Clinical Trial Access for South West Patients

Subjects
Cancer patients, Natural language interfaces -- Product development, Clinical trials, Computational linguistics -- Product development, Language processing -- Product development, Cancer, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- The NHS Cancer Alliance responsible for optimising cancer services across Somerset, Wiltshire, Avon and Gloucestershire will become the first in the United Kingdom to implement [...]

Published
2022

4. Lions led by dongles

Subjects
Set-top boxes (Television), General interest, News, opinion and commentary
Abstract

London: BMA has issued the following press release: Doctors are let down every day by poor IT in the health service. Outdated software and basic delays in accessing records make [...]

Published
2019

5. Saturday: The insiders' guide to cancer prevention: These experts spend their lives fighting cancer. They have heard every tip, sensible or not, for how to avoid it. They tell Oliver Laughland how their lifestyles have changed

Subjects
Oncology, Experimental -- Methods, Cancer -- Prevention -- Care and treatment -- Research, News, opinion and commentary
Abstract

Byline: Oliver Laughland The breast specialist Tena Walters, 51, consultant, London Breast Clinic Just this week the papers splashed on another piece of research criticising breast cancer screening, saying that [...]

Published
2012

8. Positive data presented from ongoing phase II immunotherapy study for melanoma

Subjects
Medical research, Medicine, Experimental, DNA, Antigenic determinants, Immunotherapy, Cancer -- Care and treatment, Clinical trials, Melanoma -- Drug therapy, Health, Science and technology, Drug therapy, Product development
Abstract

Oxxon Therapeutics, Inc., reported positive interim data from its ongoing phase II immunotherapy study in patients with advanced melanoma. The data were presented at an oral session at the 6th [...]

Published
2005

9. Positive data presented from ongoing phase II immunotherapy study for melanoma

Subjects
Medical research, Medicine, Experimental, DNA, Antigenic determinants, Immunotherapy, Cancer -- Care and treatment, Clinical trials, Melanoma -- Drug therapy, Health, Drug therapy, Product development
Abstract

Oxxon Therapeutics, Inc., reported positive interim data from its ongoing phase II immunotherapy study in patients with advanced melanoma. The data were presented at an oral session at the 6th [...]

Published
2005

10. Positive data reported from phase II immunotherapy study in advanced melanoma

Subjects
Medical research, Medicine, Experimental, DNA, Antigenic determinants, Immunotherapy, Cancer -- Care and treatment, Clinical trials, Melanoma -- Drug therapy, Health, Science and technology, Drug therapy, Product development
Abstract

Oxxon Therapeutics, Inc., reported positive interim data from its ongoing phase II immunotherapy study in patients with advanced melanoma. The data were presented at an oral session at the 6th [...]

Published
2005

11. Positive data reported from phase II immunotherapy study in advanced melanoma

Subjects
Medical research, Medicine, Experimental, DNA, Antigenic determinants, Immunotherapy, Cancer -- Care and treatment, Clinical trials, Melanoma -- Drug therapy, Health, Drug therapy, Product development
Abstract

Oxxon Therapeutics, Inc., reported positive interim data from its ongoing phase II immunotherapy study in patients with advanced melanoma. The data were presented at an oral session at the 6th [...]

Published
2005

12. Positive data reported from phase II immunotherapy study in advanced melanoma

Subjects
Drug therapy, Product development, Cancer treatment, Clinical trials, DNA, Medical research, Immunotherapy, Antigenic determinants, Melanoma -- Drug therapy, Medicine, Experimental, Cancer -- Care and treatment
Abstract

Oxxon Therapeutics, Inc., reported positive interim data from its ongoing phase II immunotherapy study in patients with advanced melanoma. The data were presented at an oral session at the 6th [...]

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results